Sulforaphane suppresses TARC/CCL17 and MDC/CCL22 expression through heme oxygenase-1 and NF-κB in human keratinocytes

Arch Pharm Res. 2010 Nov;33(11):1867-76. doi: 10.1007/s12272-010-1120-6. Epub 2010 Nov 30.

Abstract

Sulforaphane (4-methylsulfinylbutyl isothiocyanate, SFN) from broccoli has been used a chemopreventive photochemical as detoxification of xenobiotics and anti-inflammatory, however, there is no studies for Th2 chemokine expression through heme oxygenase-1 and NF-κB in keratinocytes. Atopic dermatitis is a chronically relapsing pruritic inflammatory skin disease. SFN is demonstrated to have anti-inflammatory and anti-oxidant effects. This study aimed to define whether and how SFN regulates Th2-related chemokine production in human HaCaT keratinocytes. The level of chemokine expression was measured by reverse transcription polymerase chain reaction (RT-PCR) and signaling study was performed by Western blot analysis. Chemokine production was determined by enzyme-linked immunosorbent assay. Pretreatment with SFN suppressed interferon-γ (IFN-γ) and tumor necrosis factor (TNF)-α- induced thymus- and activation-regulated chemokine (TARC/CCL17) and macrophage-derived chemokine (MDC/CCL22) production in HaCaT keratinocytes. SFN inhibited IFN-γ and TNF-α-induced NF-κB activation as well as STAT1 activation. Interestingly, pretreatment with SFN result in significantly suppressed IFN-γ and TNF-α-induced TARC/CCL17 and MDC/CCL22 production through the induction of HO-1. This suppression was completely abolished by HO-1 siRNA. Furthermore, Carbon monoxide, but not other end products of HO-1 activity, also suppressed IFN-γ and TNF-α-induced TARC/CCL17 and MDC/CCL22 production. These results demonstrate that SFN has an inhibitory role in IFN-γ and TNF-α-induced production of TARC/CCL17 and MDC/CCL22 in human HaCaT cells by inhibition of NF-κB activation and induction of HO-1.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Brassica
  • Chemokine CCL17 / metabolism*
  • Chemokine CCL22 / genetics
  • Chemokine CCL22 / metabolism*
  • Chemokines, CC / genetics
  • Chemokines, CC / metabolism
  • Chemoprevention
  • Dermatitis, Atopic / drug therapy
  • Dermatitis, Atopic / pathology
  • Gene Expression Regulation / drug effects
  • Heme Oxygenase-1 / genetics
  • Heme Oxygenase-1 / metabolism*
  • Humans
  • Interferon-gamma / genetics
  • Interferon-gamma / metabolism
  • Isothiocyanates
  • Keratinocytes / drug effects*
  • Keratinocytes / metabolism
  • NF-kappa B / genetics
  • NF-kappa B / metabolism*
  • Phytotherapy
  • STAT1 Transcription Factor / genetics
  • STAT1 Transcription Factor / metabolism
  • Signal Transduction / drug effects
  • Sulfoxides
  • Thiocyanates / metabolism
  • Thiocyanates / pharmacology*
  • Tumor Necrosis Factor-alpha / genetics
  • Tumor Necrosis Factor-alpha / metabolism

Substances

  • CCL17 protein, human
  • CCL22 protein, human
  • Chemokine CCL17
  • Chemokine CCL22
  • Chemokines, CC
  • Isothiocyanates
  • NF-kappa B
  • STAT1 Transcription Factor
  • STAT1 protein, human
  • Sulfoxides
  • Thiocyanates
  • Tumor Necrosis Factor-alpha
  • Interferon-gamma
  • Heme Oxygenase-1
  • sulforaphane